BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ecnoglutide readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ecnoglutide\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07073417-193@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20270227
DTEND;VALUE=DATE:20270228
SUMMARY:ecnoglutide: Phase 2 readout est. (NCT07073417)
DESCRIPTION:ecnoglutide\, phase 2\, Obesity.\nStudy: A Study to Compare XW0
 03 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLI
 MMER-UP-SWITCH)\nEstimated primary completion: 27 February 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/ecnoglutide#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07073417
URL:https://assetmemo.bio/drug/ecnoglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07936058-193@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20270415
DTEND;VALUE=DATE:20270416
SUMMARY:ecnoglutide: Phase 1 readout est. (NCT07936058)
DESCRIPTION:ecnoglutide\, phase 1\, Obesity.\nStudy: A Phase I Study to Eva
 luate the Food Effect on Ecnoglutide Tablet\nEstimated primary completion:
  15 April 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ecnog
 lutide#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07936058
URL:https://assetmemo.bio/drug/ecnoglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07929298-193@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20270903
DTEND;VALUE=DATE:20270904
SUMMARY:ecnoglutide: Phase 2 readout est. (NCT07929298)
DESCRIPTION:ecnoglutide\, phase 2\, Obesity.\nStudy: A Study to Evaluate th
 e Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With 
 Overweight or Obesity\nEstimated primary completion: 3 September 2027. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/ecnoglutide#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT07929298
URL:https://assetmemo.bio/drug/ecnoglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07387094-193@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20271216
DTEND;VALUE=DATE:20271217
SUMMARY:ecnoglutide: Phase 3 readout est. (NCT07387094)
DESCRIPTION:ecnoglutide\, phase 3\, Obesity.\nStudy: A Study of XW003 in Ob
 ese Participants With Obstructive Sleep Apnea But Not Receive Positive Air
 way Pressure Therapy\nEstimated primary completion: 16 December 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/ecnoglutide#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT07387094
URL:https://assetmemo.bio/drug/ecnoglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07734311-193@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:ecnoglutide: Phase 3 readout est. (NCT07734311)
DESCRIPTION:ecnoglutide\, phase 3\, Obesity.\nStudy: A Study of Econoglutid
 e Injection in Obese Participants With Knee Osteoarthritis (KOA)\nEstimate
 d primary completion: 31 May 2028. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/ecnoglutide#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT07734311
URL:https://assetmemo.bio/drug/ecnoglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07836270-193@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20280608
DTEND;VALUE=DATE:20280609
SUMMARY:ecnoglutide: Phase 3 readout est. (NCT07836270)
DESCRIPTION:ecnoglutide\, phase 3\, Obesity.\nStudy: A Study of Ecnoglutide
  Injection in Overweight or Obese Chinese Adolescents\nEstimated primary c
 ompletion: 8 June 2028. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/ecnoglutide#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07836270
URL:https://assetmemo.bio/drug/ecnoglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07434050-193@assetmemo.bio
DTSTAMP:20261121T005433Z
DTSTART;VALUE=DATE:20280619
DTEND;VALUE=DATE:20280620
SUMMARY:ecnoglutide: Phase 3 readout est. (NCT07434050)
DESCRIPTION:ecnoglutide\, phase 3\, Obesity.\nStudy: A Study of XW003 in Ob
 ese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pr
 essure Therapy\nEstimated primary completion: 19 June 2028. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/ecnoglutide#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT07434050
URL:https://assetmemo.bio/drug/ecnoglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
